Chai Discovery

Chai Discovery: AI Foundation Models for Biology

Chai Discovery is AI-native drug discovery building foundation models for biology. Chai Discovery is among the credible AI-native drug discovery labs alongside Isomorphic Labs and Recursion. The Chai-1 model has demonstrated state-of-the-art protein-ligand structure prediction, which is the foundational primitive most modern drug discovery workflows depend on.

Key Features

• AI-native drug discovery building foundation models for biology
• Chai-1 model — protein-ligand structure prediction state-of-the-art
• Backed by OpenAI Startup Fund and Thrive Capital
• Forbes AI 50 2026 newcomer
• Open-research approach with model weights and benchmarks released
• Targets the protein structure + drug design intersection
• Founded 2024; rapid scaling alongside Isomorphic Labs and similar

Ideal Use Case

Pharmaceutical R&D leaders, biotech founders, and AI researchers working on drug discovery — needing best-in-class protein structure prediction and drug-target interaction models.

Why Use Chai Discovery

Chai Discovery is among the credible AI-native drug discovery labs alongside Isomorphic Labs and Recursion. The Chai-1 model has demonstrated state-of-the-art protein-ligand structure prediction, which is the foundational primitive most modern drug discovery workflows depend on.

FAQ

Q: vs Isomorphic Labs? A: Isomorphic is DeepMind's drug discovery spinout (Alphabet-funded); Chai is independent and OpenAI-Startup-Fund-backed.

Q: Are models open? A: Chai-1 weights and benchmarks have been released publicly — research-led approach.

Q: Pricing? A: Enterprise R&D contracts; contact for current details.

Q: Stage? A: Forbes AI 50 2026 newcomer; rapid scaling but pre-clinical-pipeline.

tl;dr

AI-native drug discovery lab. Foundation models for biology. Forbes AI 50 2026 newcomer.

Related

Looking for more options? Browse the Healthcare directory or read our best AI healthcare tools listicle. Chai Discovery is also tracked on Crunchbase.